Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Saginova

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Terapevticheskii Arkhiv|August 10, 2007
[Renal affection in obesity]E A Saginova, V V Fomin, S V Moiseev, et al.
Terapevticheskii Arkhiv|September 25, 2012
[Clinicopathogenetic characteristics of cardiorenal syndrome in non-alcoholic fatty liver disease]M M Severova, E A Saginova, M G Galliamov, et al.
Terapevticheskii Arkhiv|August 25, 2010
[Association of obstructive sleep apnea syndrome with the signs of nonalcoholic fatty liver disease and calculated glomerular filtration rate in metabolic syndrome]M M Severova, V V Fomin, M V Lebedeva, et al.
Terapevticheskii Arkhiv|July 23, 2013
[Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity]M G Galiamov, E A Saginova, M M Severova, et al.
Terapevticheskii Arkhiv|July 27, 2011
[The role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients]E A Saginova, M G Galliamov, M M Severova, et al.
Terapevticheskii Arkhiv|September 25, 2012
[Remodeling of the cardiovascular system and development of chronic kidney disease in patients with metabolic syndrome and obesity: role of eNOS, subunit p22-phox of NADPH-oxidase and MTHFR genes]E A Saginova, M G Galliamov, A V Balatskiĭ, et al.
Terapevticheskii Arkhiv|August 8, 2006
[Development of renal affection in obese patients]E A Saginova, E Iu Fedorova, V V Fomin, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|September 6, 2007
[Endothelial dysfunction and renal lesion in obesity]N A Mukhin, V V Fomin, E A Saginova, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Terapevticheskii Arkhiv|August 10, 2007
[Renal affection in obesity]E A Saginova, V V Fomin, S V Moiseev, et al.
Terapevticheskii Arkhiv|September 25, 2012
[Clinicopathogenetic characteristics of cardiorenal syndrome in non-alcoholic fatty liver disease]M M Severova, E A Saginova, M G Galliamov, et al.
Terapevticheskii Arkhiv|August 25, 2010
[Association of obstructive sleep apnea syndrome with the signs of nonalcoholic fatty liver disease and calculated glomerular filtration rate in metabolic syndrome]M M Severova, V V Fomin, M V Lebedeva, et al.
Terapevticheskii Arkhiv|July 23, 2013
[Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity]M G Galiamov, E A Saginova, M M Severova, et al.
Terapevticheskii Arkhiv|July 27, 2011
[The role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients]E A Saginova, M G Galliamov, M M Severova, et al.
Terapevticheskii Arkhiv|September 25, 2012
[Remodeling of the cardiovascular system and development of chronic kidney disease in patients with metabolic syndrome and obesity: role of eNOS, subunit p22-phox of NADPH-oxidase and MTHFR genes]E A Saginova, M G Galliamov, A V Balatskiĭ, et al.
Terapevticheskii Arkhiv|August 8, 2006
[Development of renal affection in obese patients]E A Saginova, E Iu Fedorova, V V Fomin, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|September 6, 2007
[Endothelial dysfunction and renal lesion in obesity]N A Mukhin, V V Fomin, E A Saginova, et al.
Pageof 1